India needs Pfizer to do nearby examination for approval: Official Kumar Jeetendra | January 13, 2021 Any vaccine manufacturer, such as Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must run a neighborhood”bridging” safety and immunogenicity study to be considered for the country’s immunisation programme, a senior government official told Reuters. Serum Institute of India, the local maker of the vaccine developed by AstraZeneca Plc and …
Waters APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130 Kumar Jeetendra | January 16, 2021 Waters Corporation (NYSE:WAT) today announced that its Xevo TQ-XS atmospheric pressure gas chromatography (APGC) mass spectrometry (MS) platform is an accepted alternative for the identification and quantification of dioxins and furans in environmental samples. Dioxins are a byproduct of human industrial activity and their effects on human health are well documented1. The acceptance of Method …
Industry looks for interest in COVID-19 immunization program: CII Kumar Jeetendra | February 18, 2021 Indian industry has sought involvement from the continuing COVID-19 vaccination programme in order to help the government reach its identified target priority groups quicker, which is crucial for getting the workforce back to work and the economy back on track, the Confederation of Indian Industry (CII) said on Thursday. To action the successful roll out …
Ordinary promoter vaccines are the future fighting with COVID-19 infection, top genome experts says Kumar Jeetendra | March 15, 2021 Standard booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, the head of Britain’s attempt to sequence the virus’s genomes told Reuters. The novel coronavirus, which has killed 2.65 million individuals globally since it emerged in China in late 2019, …
Vaccines may require regular updates as Covid develops, say researchers Kumar Jeetendra | March 27, 2021 A health worker checks the Covishied, a COVID-19 vaccine manufactured by Serum Institute of India, as she prepares to start vaccination against COVID-19 in Kathmandu, Nepal January 27, 2021. (Reuters/Navesh Chitrakar) Scientists have assessed the course of development of the novel coronavirus and predicted that COVID-19 vaccines currently in use across the world may need …
Sputnik V vaccine authorized in India Kumar Jeetendra | April 13, 2021 Moscow, April 13, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country. India has become the 60th country to approve Sputnik V. Sputnik V is one of only three …
Sri Lanka endorses Pfizer COVID-19 vaccine for emergency use Kumar Jeetendra | May 8, 2021 Sri Lanka on Saturday approved Pfizer’s COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India. Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 …
What is the Moderna COVID immunization? Does it work, and is it safe? Kumar Jeetendra | May 16, 2021 Overnight, Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. The deal includes ten million doses against the original strain of the coronavirus to be delivered this year. This vaccine has been widely used in countries such as Canada, United States and the United Kingdom …
Too soon to say second wave has topped; immunization accessibility national bottleneck: CRISIL Kumar Jeetendra | May 17, 2021 Even as new COVID-19 infections have shown a declining trend, credit rating agency Crisil on Monday said it is “too early” to say that the second wave of the pandemic has peaked and flagged concerns over the vaccination drive. After opening up the vaccination for all adults, the drive has suffered because availability of vaccines …
Singapore endorses Pfizer-BioNTech COVID-19 antibody for use in 12 to 15-year-olds Kumar Jeetendra | May 18, 2021 Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old in a bid to extend protection to more groups as the country tackles a recent increase of infections, officials said on Tuesday.“The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in …
More youngsters contaminated with COVID, no requirement for panic but important to immunize: Experts Kumar Jeetendra | May 25, 2021 More children are testing positive in the second Covid wave but the infection is mostly mild and the mortality rate low, say experts, citing increased testing and enhanced understanding of symptoms as among the possible reasons for the rising graph. Though there is enough anecdotal evidence of COVID-19 catching children – early teens and younger …
Another COVID-19 immunization enters last trial phase Kumar Jeetendra | May 27, 2021 Production of another potential vaccine against COVID-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they launched a large Phase III trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin America. The study will test the effectiveness of vaccine candidate formulas against the virus that spread from …
